Fig. 2From: Evaluating the predictive performance of malaria antibodies and FCGR3B gene polymorphisms on Plasmodium falciparum infection outcome: a prospective cohort studyDiscrimination and calibration ability of the three final models. FMNS = Final model with no shrinkage, SCOV Final model with slope corrected optimism using Van Howelligen estimator, NBV Model with no baseline variables (only IgGAMA1, IgG1AMA1, and dominant gene c.233C>A); BCV Bootstrap cross-validationBack to article page